447 related articles for article (PubMed ID: 34211157)
21. The role of glycoprotein 130 family of cytokines in fetal rat lung development.
Nogueira-Silva C; Piairo P; Carvalho-Dias E; Veiga C; Moura RS; Correia-Pinto J
PLoS One; 2013; 8(6):e67607. PubMed ID: 23826327
[TBL] [Abstract][Full Text] [Related]
22. GP130 cytokines and bone remodelling in health and disease.
Sims NA; Walsh NC
BMB Rep; 2010 Aug; 43(8):513-23. PubMed ID: 20797312
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
[TBL] [Abstract][Full Text] [Related]
24. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 controls recycling and degradation, but not internalization of its receptors.
Flynn CM; Kespohl B; Daunke T; Garbers Y; Düsterhöft S; Rose-John S; Haybaeck J; Lokau J; Aparicio-Siegmund S; Garbers C
J Biol Chem; 2021; 296():100434. PubMed ID: 33610555
[TBL] [Abstract][Full Text] [Related]
26. The Role of gp130 Cytokines in Tuberculosis.
Ritter K; Rousseau J; Hölscher C
Cells; 2020 Dec; 9(12):. PubMed ID: 33334075
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease.
Rose-John S; Mitsuyama K; Matsumoto S; Thaiss WM; Scheller J
Curr Pharm Des; 2009; 15(18):2095-103. PubMed ID: 19519447
[TBL] [Abstract][Full Text] [Related]
28. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.
Fischer P; Hilfiker-Kleiner D
Basic Res Cardiol; 2007 Jul; 102(4):279-97. PubMed ID: 17530315
[TBL] [Abstract][Full Text] [Related]
29. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
30. Different protein turnover of interleukin-6-type cytokine signalling components.
Siewert E; Müller-Esterl W; Starr R; Heinrich PC; Schaper F
Eur J Biochem; 1999 Oct; 265(1):251-7. PubMed ID: 10491180
[TBL] [Abstract][Full Text] [Related]
31. Combined deletion of the fibronectin-type III domains and the stalk region results in ligand-independent, constitutive activation of the Interleukin 6 signal-transducing receptor gp130.
Lamertz L; Floss DM; Scheller J
Cytokine; 2018 Oct; 110():428-434. PubMed ID: 29789201
[TBL] [Abstract][Full Text] [Related]
32. Conditional gp130 deficient mouse mutants.
Fasnacht N; Müller W
Semin Cell Dev Biol; 2008 Aug; 19(4):379-84. PubMed ID: 18687405
[TBL] [Abstract][Full Text] [Related]
33. Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.
Miller A; Brooks GD; McLeod L; Ruwanpura S; Jenkins BJ
Oncogene; 2015 Mar; 34(12):1510-9. PubMed ID: 24727895
[TBL] [Abstract][Full Text] [Related]
34. Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: purification via inverse transition cycling.
Lin M; Rose-John S; Grötzinger J; Conrad U; Scheller J
Biochem J; 2006 Sep; 398(3):577-83. PubMed ID: 16716147
[TBL] [Abstract][Full Text] [Related]
35. Myeloid cells require gp130 signaling for protective anti-inflammatory functions during sepsis.
Sackett SD; Otto T; Mohs A; Sander LE; Strauch S; Streetz KL; Kroy DC; Trautwein C
FASEB J; 2019 May; 33(5):6035-6044. PubMed ID: 30726111
[TBL] [Abstract][Full Text] [Related]
36. Exploring the landscape of synthetic IL-6-type cytokines.
Scheller J; Ettich J; Wittich C; Pudewell S; Floss DM; Rafii P
FEBS J; 2024 May; 291(10):2030-2050. PubMed ID: 37467060
[TBL] [Abstract][Full Text] [Related]
37. Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases.
Fujio Y; Maeda M; Mohri T; Obana M; Iwakura T; Hayama A; Yamashita T; Nakayama H; Azuma J
J Pharmacol Sci; 2011; 117(4):213-22. PubMed ID: 22056652
[TBL] [Abstract][Full Text] [Related]
38. Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease.
Min HK; Mirshahi F; Verdianelli A; Pacana T; Patel V; Park CG; Choi A; Lee JH; Park CB; Ren S; Sanyal AJ
Am J Physiol Gastrointest Liver Physiol; 2015 May; 308(9):G794-803. PubMed ID: 25747354
[TBL] [Abstract][Full Text] [Related]
39. The multi-site docking protein Grb2-associated binder 1 (Gab1) enhances interleukin-6-induced MAPK-pathway activation in an SHP2-, Grb2-, and time-dependent manner.
Bongartz H; Gille K; Hessenkemper W; Mandel K; Lewitzky M; Feller SM; Schaper F
Cell Commun Signal; 2019 Oct; 17(1):135. PubMed ID: 31651330
[TBL] [Abstract][Full Text] [Related]
40. A gp130-Src-YAP module links inflammation to epithelial regeneration.
Taniguchi K; Wu LW; Grivennikov SI; de Jong PR; Lian I; Yu FX; Wang K; Ho SB; Boland BS; Chang JT; Sandborn WJ; Hardiman G; Raz E; Maehara Y; Yoshimura A; Zucman-Rossi J; Guan KL; Karin M
Nature; 2015 Mar; 519(7541):57-62. PubMed ID: 25731159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
